QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

RMD

QT65ResMed Inc.
NYSE·Healthcare·Medical - Devices·USA
Latest market price
188.63
+2.34+1.26%
OverviewShort InterestFilings
RMDQT65ResMed Inc.·NYSE
OverviewShort InterestFilings
188.63+1.26%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47PHG+2.06%$26.78
Snapshot
Index-P/E17.96EPS (ttm)10.34
Insider Own0.95%
Shs Outstand145.06M
Perf Week-1.95%
Market Cap27.02BForward P/E15.41EPS next Y12.24Insider Trans0.01%Shs Float-Perf Month-9.22%
Enterprise Value26.21BPEG1.12EPS next Q2.90Inst Own-Short Float-Perf Quarter-17.05%
Income1.51BP/S4.88EPS this Y7.46%Inst Trans-Short Ratio-Perf Half Y-23.74%
Sales5.54BP/B4.20EPS next Y10.16%ROA17.30%Short Interest-Perf YTD-21.69%
Book/sh44.75P/C14.44EPS next 5Y9.80%ROE24.41%52W High293.82 -35.80%Perf Year-24.58%
Cash/sh11.45P/FCF15.46EPS past 3/5Y-ROIC19.63%52W Low180.27 4.64%Perf 3Y-
Dividend Est.2.40 (1.27%)EV/EBITDA12.38Sales past 3/5Y12.88% 11.72%Gross Margin61.69%Volatility2.16% 2.05%Perf 5Y-
Dividend TTM2.40 (1.27%)EV/Sales4.73EPS Y/Y TTM48.55%Oper. Margin34.28%ATR (14)5.60Perf 10Y-
Dividend Ex-DateMay 14, 2026Quick Ratio2.33Sales Y/Y TTM18.21%Profit Margin27.44%RSI (14)39.13Recom2.57
Dividend Gr. 3/5Y9.53% 7.70%Current Ratio3.01EPS Q/Q15.64%SMA20-3.36%Beta0.53Target Price264.86
Payout22.39%Debt/Eq0.13Sales Q/Q10.76%SMA50-8.90%Rel Volume2.67Prev Close186.29
Employees9,980LT Debt/Eq0.14EarningsJul 30SMA200-22.24%Avg Volume1.45MPrice188.63
IPO DateJun 02, 1995Option/ShortYes / YesEPS/Sales Surpr.2.55% 1.57%Net Debt/EBITDA-0.39Volume3,878,511Change1.26%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-17-26DowngradeMorgan StanleyOverweight → Equal Weight$305 → $230
May-01-26ReiteratedRobert W. Baird$254 → $225
Apr-27-26ReiteratedKeybancOverweight$302 → $290
Apr-13-26ReiteratedEvercore ISI$300 → $255
Jan-30-26ReiteratedStifel Nicolaus$260 → $265
Jan-30-26ReiteratedKeyBancOverweight$299 → $302
Jan-30-26ReiteratedRobert W. Baird$275 → $281
Jan-30-26ReiteratedRBC CapitalOutperform$224 → $314
Jan-30-26ReiteratedPiper SandlerNeutral$260 → $275
Dec-18-25ReiteratedStifel Nicolaus$240 → $260
Latest News
Jun-18-26
Jun-18-2603:17PM
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and SonosYahoo
10:50AM
Morgan Stanley Downgrades ResMed (RMD)Fintel
10:31AM
Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga
Jun-17-26
Jun-17-2608:51PM
Why ResMed (RMD) Shares Are Falling TodayYahoo
08:35PM
Stocks Retreat as Fed Signals Possible Higher Interest RatesYahoo
07:38PM
Sector Update: Healthcare Stocks Retreat Late AfternoonYahoo
07:05PM
Stay informed with the top movers within the S&P500 index on Wednesday.ChartMill
03:22PM
Stocks Mixed Ahead of FOMC Meeting ResultsYahoo
02:09PM
Stocks Supported by Chip Stock Strength and Strong US Retail SalesYahoo
01:47PM
Lyft upgraded, Leidos downgraded: Wall Street's top analyst callsYahoo
10:37AM
Nasdaq Futures Climb as Chip Stocks Rebound Ahead of First Fed Decision Under WarshYahoo
09:13AM
This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For WednesdayBenzinga
09:05AM
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga
08:42AM
Morgan Stanley Downgrades ResMed to Equal-Weight, Lowers Price Target to $230Benzinga
Jun-15-26
Jun-15-2604:17AM
ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation SignalsYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
6/30/2025
FY 2024
6/30/2024
FY 2023
6/30/2023
FY 2022
6/30/2022
FY 2021
6/30/2021
FY 2020
6/30/2020
FY 2019
6/30/2019
FY 2018
6/30/2018
Total Revenue5,5385,1464,685
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,1212,0912,030
Gross Profit3,4173,0552,655
Selling, General and Administrative Excl. Other1,082991917
Research and Development358331308
Other Operating Expense7848110
Operating Income1,9001,6851,320
Interest Expense291346
Unusual Expense
———
Non-Operating Income (Expense)-33109
Net Income Before Taxes1,9031,6781,265
Income Taxes384277244
Consolidated Net Income1,5211,4011,021
Net Income From Continuing Operations1,5211,4011,021
Net Income1,5211,4011,021
EPS (Recurring)10.389.556.94
EPS (Basic, Before Extraordinaries)10.389.556.94
EPS (Diluted)10.349.516.92
EBITDA2,1851,9131,534
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio18.2427.13—
Price To Sales Ratio4.977.37—
Gross Margin61.7059.3756.67
Operating Margin34.3132.7428.18
Net Margin27.4627.2321.79
Shares Outstanding146147147
Market Capitalization27,54037,926—
Operating Lease Expense
———
Insider Trading Volume
$204.36$189.17$173.97$158.78$143.59● Close Price0.00M0.97M1.95M2.92M3.89MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Farrell Michael J.Chairman and CEOJun 08 '26Option Exercise146.349,9821,460,766471,214Jun 09 12:00 AM
Farrell Michael J.Chairman and CEOJun 08 '26Sale193.964,991968,064466,256Jun 09 12:00 AM
Farrell Michael J.Chairman and CEOMay 07 '26Option Exercise146.349,9821,460,766471,214May 11 12:00 AM
Farrell Michael J.Chairman and CEOMay 07 '26Sale207.824,9911,037,233466,223May 11 12:00 AM
Farrell Michael J.Chairman and CEOApr 07 '26Sale225.504,9911,125,486466,223Apr 09 12:00 AM
Farrell Michael J.Chairman and CEOApr 07 '26Option Exercise146.349,9821,460,766471,214Apr 09 12:00 AM
Sandercock BrettChief Financial OfficerApr 01 '26Sale224.311,000224,31083,495Apr 03 12:00 AM
FARRELL PETER CDirectorApr 01 '26Sale225.002,000450,00060,773Apr 02 12:00 AM
Farrell Michael J.Chairman and CEOMar 09 '26Option Exercise146.349,9821,460,766471,214Mar 11 12:00 AM
Farrell Michael J.Chairman and CEOMar 09 '26Sale251.034,9911,252,902466,223Mar 11 12:00 AM
FARRELL PETER CDirectorMar 04 '26Sale260.222,000520,44062,773Mar 05 12:00 AM
Sandercock BrettChief Financial OfficerMar 02 '26Sale254.301,000254,30084,495Mar 03 12:00 AM
Farrell Michael J.Chairman and CEOFeb 09 '26Option Exercise146.349,9821,460,766471,214Feb 10 12:00 AM
Farrell Michael J.Chairman and CEOFeb 09 '26Sale273.784,9911,366,436466,223Feb 10 12:00 AM
FARRELL PETER CDirectorFeb 04 '26Sale251.312,000502,62064,773Feb 06 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR